March 3, 2025
WEST PALM BEACH, Fla. — Discontinuing disease-modifying therapies (DMTs) for multiple sclerosis (MS) after prolonged disease stability poses minimal risk for patients aged > 60 years, […]
March 3, 2025
TOPLINE: Cognitive function may decline more quickly in patients with dementia who also have rheumatoid arthritis (RA), a new cohort study suggested. Having dementia and RA […]
March 3, 2025
As biomarker testing for Alzheimer’s disease (AD) evolves, timely and compassionate disclosure of a diagnosis is more complex than ever. Yet, clinicians may struggle with how […]
February 28, 2025
TOPLINE: Smoking was associated with a doubling in risk for cryptogenic ischemic stroke (CIS), with the strongest association in men and those aged 45-49 years in […]
February 27, 2025
Stroke is often seen as a crisis of the moment — an acute medical emergency where the first 24-48 hours are critical for survival. But for […]
February 26, 2025
Feb. 25, 2025 — The FDA has approved a new treatment plan for a long-acting injection, making it easier for people with moderate to severe opioid […]
February 24, 2025
The US Food and Drug Administration (FDA) has approved the first adaptive deep brain stimulation (aDBS) system for Parkinson’s disease (PD) that self-adjusts therapy to individual […]
February 24, 2025
The first platform trial for amyotrophic lateral sclerosis (ALS), which individually evaluated four experimental drugs, failed to meet key primary endpoints. Still, investigators view the trial […]
February 21, 2025
The National Institute for Health and Care Excellence (NICE) has issued final draft guidance recommending fenfluramine (Fintepla) for treating seizures associated with Lennox-Gastaut syndrome. The recommendation […]